Drug intelligence / Profile preview

3Mix

Development stage
Unknown
Lead developer
Cairo University
Modality
Small Molecules
Administration
Topical
01

Overview

3Mix is a triple antibiotic paste used in dentistry for Lesion Sterilization and Tissue Repair (LSTR). Originally developed by Hoshino et al., the standard formulation typically consists of a combination of ciprofloxacin, metronidazole, and minocycline. In clinical practice, a 'Modified 3Mix' is often used, which replaces minocycline with clindamycin or cefaclor to prevent tooth discoloration. The paste is applied topically to the pulp or root canal system of necrotic teeth, particularly in pediatric dentistry for primary molars, to achieve profound disinfection of the endodontic space and periradicular tissues. It works by targeting a broad spectrum of endodontic pathogens, including gram-positive and gram-negative bacteria as well as obligate and facultative anaerobes.

Other names
triple antibiotic pasteHoshino's pasteModified 3MixModified3MixModified-3Mix
02

Targets

DNA gyraseBacterial 50S ribosomal subunitTopo IV (Bacterial Topoisomerase IV)Bacterial deoxyribonucleic acid (DNA)Bacterial Ribosome

Beyond the preview

Go deeper on 3Mix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3Mix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call